If cancer is in the ethmoid sinus, treatment may include the following: Surgery followed by radiation therapy. A clinical trial of combination chemotherapy before surgery or radiation therapy. A clinical trial of combination chemotherapy after surgery or other cancer treatment.
This report contains market size and forecasts of Paranasal Sinus Cancer Treatment in Global, including the following market information:
Global Paranasal Sinus Cancer Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Paranasal Sinus Cancer Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Paranasal Sinus Cancer Treatment include AbbVie, Inc., Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Roche, Becton Dickinson, Novartis AG, Ipsen Biopharmaceuticals Inc. and Thermo Fisher Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Paranasal Sinus Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Paranasal Sinus Cancer Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Paranasal Sinus Cancer Treatment Market Segment Percentages, by Type, 2021 (%)
Surgery
Radiotherapy
Chemotherapy
Global Paranasal Sinus Cancer Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Paranasal Sinus Cancer Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital and Clinics
Cancer Treatment and Research Center
Research Laboratories
Others
Global Paranasal Sinus Cancer Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Paranasal Sinus Cancer Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Paranasal Sinus Cancer Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Paranasal Sinus Cancer Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie, Inc.
Pfizer Inc.
Eli Lilly and Company
Bristol-Myers Squibb Company
Roche
Becton Dickinson
Novartis AG
Ipsen Biopharmaceuticals Inc.
Thermo Fisher Scientific
Abbott
GE Healthcare
Agilent Technologies Inc.
AstraZeneca
Boehringer Ingelheim
Bayer